Alloimmunization with Rhesus factor (Rh) D, Rhc, or Kell antibodies can place the fetus at risk for severe anemia requiring intrauterine transfusions, hydrops fetalis, or fetal demise.2 This evidence concerns the gene RHCE and anemia (phenotype).